CellCentric vs Khartis Therapeutics, Inc.
CellCentric vs Khartis Therapeutics, Inc., compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Khartis Therapeutics, Inc. on 53/100.
Where each one leads
CellCentric
- our overall score: 60/100 against 53/100
- funding raised: $375M against $50.0M
Khartis Therapeutics, Inc.
- agent readiness: 50/100 against 32/100
At a glance
| Measure | CellCentric | Khartis Therapeutics, Inc. |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. | Developing oral small molecule medicines for immunological and chronic diseases. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2003 | 2021 |
| Headquarters | Cambridge, United Kingdom | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CellCentric | Khartis Therapeutics, Inc. |
|---|---|---|
| Employees | 53 | Not published |
| Total funding | $375M | $50.0M |
| Latest round | Series D | Series B |
| LinkedIn followers | 28,695 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellCentric | Khartis Therapeutics, Inc. |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 53/100 |
| Traction | 57/100 | 38/100 |
| Team | 60/100 | 50/100 |
| Search visibility | 44/100 | Not published |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 35/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellCentric | Khartis Therapeutics, Inc. |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CellCentric vs Khartis Therapeutics, Inc.: common questions
Which is better, CellCentric or Khartis Therapeutics, Inc.?
On our 0-100 score CellCentric rates higher (60/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do CellCentric and Khartis Therapeutics, Inc. compare on the numbers?
CellCentric leads on our overall score (60/100 against 53/100), funding raised ($375M against $50.0M). Khartis Therapeutics, Inc. leads on agent readiness (50/100 against 32/100).
Read the full CellCentric review and pricing or the Khartis Therapeutics, Inc. review and pricing. You can also browse other CellCentric alternatives we track.